Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.220
+0.030 (2.52%)
At close: Mar 23, 2026, 4:00 PM EDT
1.220
0.00 (0.00%)
Pre-market: Mar 24, 2026, 8:43 AM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $4.54 million as of March 24, 2026. Its market cap has increased by 43.67% in one year.
Market Cap
4.54M
Enterprise Value
-5.47M
1-Year Change
43.67%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $4.54M, a decrease of -94.99%. That is a compound annual growth rate of -42.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 4.54M | -4.20% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silo Pharma | 4.79M |
| Akari Therapeutics, | 4.65M |
| Bio Green Med Solution | 4.61M |
| Azitra | 4.58M |
| Quince Therapeutics | 4.45M |
| VivoSim Labs | 4.38M |
| Genprex | 4.36M |
| Biodexa Pharmaceuticals | 4.34M |